Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-04 Purchase |
2022-10-06 08:30 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
346 | $0.57 | $197 | 178,415 (Indirect Direct) |
View |
| 2022-09-26 Purchase |
2022-09-27 08:01 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
18,867 | $0.55 | $10,377 | 178,069 (Indirect Direct) |
View |
| 2022-02-14 Purchase |
2022-02-22 4:59 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
3,000 | $4.4 | $13,200 | 159,202 (Indirect Direct) |
View |
| 2022-02-08 Purchase |
2022-02-10 5:05 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
2,000 | $4.835 | $9,670 | 156,202 (Indirect Direct) |
View |
| 2022-02-03 Purchase |
2022-02-07 09:00 am |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
6,000 | $5.125 | $30,750 | 154,202 (Indirect Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 5:50 pm |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
5,000 | $5.303 | $26,515 | 148,202 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 4:10 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
119,486 | $0 | 119,486 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 5:59 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
1,275,000 | $0 | 2,550,000 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:13 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
1,275,000 | $0 | 1,275,000 (Direct) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO |
5,312,983 | $0 | 5,795,408 (Direct) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO |
275 | $1000 | 5,795,408 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 6:25 pm |
N/A 2034-06-12 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
800 | $0 | 800 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 9:27 pm |
N/A 2034-03-24 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
572,182 | $0 | 572,182 (Direct) |
View |
| 2024-02-19 Option Award |
2024-02-21 5:25 pm |
N/A 2034-02-18 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2024-02-14 Other |
2024-02-16 7:37 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
1,730 | $1000 | 6,268,026 (Indirect) |
View |
| 2024-02-14 Option Award |
2024-02-16 7:37 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
100 | $1000 | 6,268,026 (Direct) |
View |
| 2024-02-14 Other |
2024-02-16 7:37 pm |
2024-03-15 2029-02-14 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
6,133,669 | $0 | 6,268,026 (Indirect) |
View |
| 2024-02-14 Exercise |
2024-02-16 7:37 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
0 | $0 | 6,268,026 (Indirect) |
View |
| 2024-02-14 Exercise |
2024-02-16 7:37 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director |
1,555 | $1000 | 6,268,026 (Indirect) |
View |
| 2023-06-22 Option Award |
2023-06-22 8:09 pm |
N/A 2033-06-21 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 4:07 pm |
N/A 2033-01-19 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
35,938 | $0 | 35,938 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 6:39 pm |
N/A 2032-06-08 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-10-08 Other |
2021-10-12 7:36 pm |
N/A N/A |
PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner |
36,733 | $10 | 5,682,977 (Indirect) |
View |
| 2021-10-08 Other |
2021-10-12 7:36 pm |
N/A N/A |
PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner |
101,241 | $0 | 5,682,977 (Indirect) |
View |
| 2021-10-06 Option Award |
2021-10-08 5:22 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2021-10-05 6:54 pm |
N/A N/A |
PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and and Secretary 10% Owner |
0 | $0 | 5,674,020 (Indirect) |
View |
| 2021-08-25 Conversion |
2021-08-27 6:53 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director |
143,202 | $0 | 144,236 (Indirect) |
View |
| 2021-01-12 Other |
2021-01-14 7:46 pm |
N/A N/A |
Locust Walk Acquisition Corp. | LWAC | Ehrlich Christopher B See Remarks |
23,750 | $0 | 4,511,250 (Indirect) |
View |
Ownership |
2021-01-07 8:50 pm |
N/A N/A |
Locust Walk Acquisition Corp. | LWAC | Ehrlich Christopher B Chief Executive Officer 10% Owner |
0 | $0 | 5,261,667 (Indirect) |
View |